Ophthalmic and aural compositions containing diclofenac potassium
Patent 5891913 Issued on April 6, 1999. Estimated Expiration Date: 
August 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesStabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use Patent #: 4960799 InventorsAssigneeApplicationNo. 809434 filed on 08/27/1997US Classes:514/567, Benzene ring nonionically bonded514/912, OPHTHALMIC514/913GlaucomaExaminersPrimary: Fay, ZohrehAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/195Foreign Application Priority Data1994-10-10 EPAbstractThe present invention describes an ophthalmic composition diclofenac potassium, the use of said composition as a medicament for treating inflammatory conditions of the eye, for treating glaucoma or for treating ear inflammatory conditions and/or painful conditions (otitis)-l as well as the use of diclofenac potassium in the preparation of a pharmaceutical composition for the treatment of any inflammatory condition of the eye, for treating glaucoma or for treating ear inflammatory and/or painful conditions (otitis).Other References
| |
